Pattern Electroretinogram Assessment during Ibopamine Test in Ocular Hypertension

Abstract

Purpose

To determine the change in pattern electroretinogram (PERG) amplitude during the ibopamine test in patients with ocular hypertension (OHT).

Methods

A total of 32 eyes (16 patients) with OHT (8 male, 8 female), mean age 54.19 years (range 22–76 years), mean baseline intraocular pressure (IOP) 23 ± 2 mm Hg, received a PERG assessment in both eyes every 5 minutes from baseline to 60 minutes. All the patients were pretreated by thymoxamine eyedrops to avoid the mydriatic effect of ibopamine. All the data were evaluated by descriptive statistics and paired t test. The results were considered with a significance level of p<0.05.

Results

All the patients enrolled matched the inclusion criteria and they did not have any local or systemic effects with the ibopamine test. The mean PERG amplitude decreased significantly from baseline after 45 minutes during the ibopamine test (paired t test = 0.05). The results were statistically not correlated with the positivity to the ibopamine test (p = 0.5).

Conclusions

These data stress that, even in presence of a moderate and transient IOP increase, inner retinal function of patients with OHT may be transiently affected.

Keywords

Glaucoma Ibopamine Ocular hypertension Pattern electroretinogram

Get full access to this article

View all access options for this article.

References

Virno

, Pecori-Giraldi

, Taverniti

. Ibopamine. D-1 dopaminergic agonist in the physiopathology of intraocular pressure. I.N.C. Editor, 2003.

Giuffrè

, Taverniti

, Di Staso

. The effects of 2% ibopamine eye drops on the intraocular pressure and pupil motility of patients with open-angle glaucoma. Eur J Ophthalmol 2004; 14: 508–13.

Giuffrè

. Ibopamine stimulates α-adrenergic receptors and D1 dopaminergic receptors in the eye. Current Drug Therapy 2007; 2: 127–32.

Scuderi

G.L.

, Regine

, Perdicchi

, Turtoro

, Contestabile

M.T.

. Efficacy of 2% ibopamine on the dilation of patients with pseudoexfoliation syndrome. Eur J Ophthalmol 2010; 20: 120–3.

Virno

, Sampaolesi

, Pecori Giraldi

. Ibopamine: D1-dopaminergic agonist in the diagnosis of glaucoma. J Glaucoma Epub 2011 Sep 22.

Ganteris-Gerritsen

, Ugahary

L.C.

, Jansen

, Mulder

P.G.

, Cohen

A.F.

, van Meurs

J.C.

. Six months treatment with ibopamine in patients with hypotony after vitreoretinal surgery for retinal detachment, uveitis or penetrating trauma. Retina 2012; 32: 742–7.

Falsini

, Marangoni

, Salgarello

. Structure-function relationship in ocular hypertension and glaucoma: interindividual and interocular analysis by OCT and pattern ERG. Graefes Arch Clin Exp Ophthalmol 2008; 246: 1153–62.

Ventura

L.M.

, Sorokac

, De Los Santos

, Feuer

W.J.

, Porciatti

. The relationship between retinal ganglion cell function and retinal nerve fiber thickness in early glaucoma. Invest Ophthalmol Vis Sci 2006; 47: 3904–11.

Riva

C.E.

, Salgarello

, Logean

, Colotto

, Galan

E.M.

, Falsini

. Flicker-evoked response measured at the optic disc rim is reduced in ocular hypertension and early glaucoma. Invest Ophthalmol Vis Sci 2004; 45: 3662–8.

10.

Colotto

, Falsini

, Salgarello

, Buzzonetti

, Cermola

, Porrello

. Transiently raised intraocular pressure reveals pattern electroretinogram losses in ocular hypertension. Invest Ophthalmol Vis Sci 1996; 37: 2663–70.